Amgen's weight loss drug Maritide clinical study shows an average weight loss effect of 20%

2025-06-24 02:44:51

Amgen's weight loss drug Maritide showed an average weight loss of 20% in a Phase II, Part I clinical study.

weight loss drug

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Xiaohongshu's commercial director responds to resignation
                            2025-06-20

                                    Espressif: Wi-Fi 7 and AI computing chips will be launched in the next two to three years
                            2025-06-19

                                    Hong Kong Stocks Midday Review: Mainland banking and insurance stocks drive the market to strengthen; Hang Seng Index closed up 1.15%
                            2025-06-20

                                    JD.com: Stablecoin is being tested in the Hong Kong Monetary Authority and is expected to be launched in the fourth quarter of this year
                            2025-06-19

                                    CITIC Securities: Tesla robotaxi begins operation, new cars, domestic demand and exports remain the main lines
                            2025-06-25